Showing results (201-210 of 1,177) with videos related to
Sort By:
Pageof 118
Applied Health Economics and Health Policy|November 19, 2003
Economics and decisions to end life: van Acht and Stooker revisitedPaul A Scuffham, Matthew J TaylorApplied Health Economics and Health Policy|November 19, 2003
Why does economic analysis in health care not get implemented more? Towards a greater understanding of the rules of the game and the costs of decision makingStephen JanApplied Health Economics and Health Policy|January 26, 2007
Analysis of healthcare financing, supply and utilisation trends in the new EU countriesJane E RuseskiApplied Health Economics and Health Policy|December 30, 2009
Is the societal approach wide enough to include relatives? Incorporating relatives' costs and effects in a cost-effectiveness analysisThomas Davidson, Lars-Ake LevinApplied Health Economics and Health Policy|November 19, 2003
Cost-benefit analysis of ambulance and rescue helicopters in Norway: reflections on assigning a monetary value to saving a human lifeRune ElvikApplied Health Economics and Health Policy|September 29, 2023
Child-Parent Agreement in the Assessment of Health-Related Quality of Life Using the CHU9D and the PedsQLTMDiana Khanna, Jyoti Khadka, Christine Mpundu-Kaambwa, et al.Applied Health Economics and Health Policy|April 15, 2026
Costs and Budget Impact of a Health System Strengthening Intervention for Hypertension and Cardiovascular Disease Care in GhanaKavita Singh, Eugene Kallson, Elom Hillary Otchi, et al.Applied Health Economics and Health Policy|March 31, 2026
Agreement in Qualitative and Quantitative Assessments of Disease Severity: Evidence from Pharmaceutical Reimbursement in SwedenMartin Henriksson, Lars Sandman, Jonathan SiverskogApplied Health Economics and Health Policy|February 23, 2026
Towards a Multi-sectoral Approach to Population Health: A Scoping Review of Cross-sectoral Evaluations of Health InterventionsRositsa Koleva-Kolarova, Emily Hulse, Bertalan Németh, et al.Applied Health Economics and Health Policy|February 25, 2026
Economic Evaluation of Bruton's Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukaemia in South AfricaRochelle Woudberg, Edina SinanovicPageof 118